LUCIDA MEDICAL LTD

Company Registration Number:
12320979 (England and Wales)

Unaudited abridged accounts for the year ended 31 March 2025

Period of accounts

Start date: 01 April 2024

End date: 31 March 2025

LUCIDA MEDICAL LTD

Contents of the Financial Statements

for the Period Ended 31 March 2025

Balance sheet
Notes

LUCIDA MEDICAL LTD

Balance sheet

As at 31 March 2025


Notes

2025

2024


£

£
Fixed assets
Tangible assets: 3 5,509 4,796
Total fixed assets: 5,509 4,796
Current assets
Debtors:   416,167 525,351
Cash at bank and in hand: 198,270 493,862
Total current assets: 614,437 1,019,213
Creditors: amounts falling due within one year:   (335,422) (309,557)
Net current assets (liabilities): 279,015 709,656
Total assets less current liabilities: 284,524 714,452
Creditors: amounts falling due after more than one year:   0 (189,130)
Total net assets (liabilities): 284,524 525,322
Capital and reserves
Called up share capital: 285 240
Share premium account: 5,536,534 4,281,390
Other reserves: 158,825 86,950
Profit and loss account: (5,411,120) (3,843,258)
Shareholders funds: 284,524 525,322

The notes form part of these financial statements

LUCIDA MEDICAL LTD

Balance sheet statements

For the year ending 31 March 2025 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 23 July 2025
and signed on behalf of the board by:

Name: Dr. A. W. Rix
Status: Director

The notes form part of these financial statements

LUCIDA MEDICAL LTD

Notes to the Financial Statements

for the Period Ended 31 March 2025

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

Turnover policy

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets and depreciation policy

Depreciation is provided at annual rates in order to write off each asset over its estimated useful life.

Other accounting policies

Taxation Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. Current or deferred taxation assets and liabilities are not discounted. Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date. Hire purchase and leasing commitments Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease. Pension costs and other post-retirement benefits The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate. Going concern The directors have considered the financial position of the company and believe it is well placed to manage its business risks successfully. The directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus the going concern basis of preparing the financial statements will continue to be adopted.

LUCIDA MEDICAL LTD

Notes to the Financial Statements

for the Period Ended 31 March 2025

2. Employees

2025 2024
Average number of employees during the period 15 14

LUCIDA MEDICAL LTD

Notes to the Financial Statements

for the Period Ended 31 March 2025

3. Tangible Assets

Total
Cost £
At 01 April 2024 27,143
Additions 4,313
At 31 March 2025 31,456
Depreciation
At 01 April 2024 22,347
Charge for year 3,600
At 31 March 2025 25,947
Net book value
At 31 March 2025 5,509
At 31 March 2024 4,796